In The Press

NovelStem Announces FDA Pre-Submission and EMA In Vitro Diagnostic Device Filing for Revolutionary

NovelStem Reviews Efforts to Maximize Value from Legacy Entertainment Asset

NovelStem Files Preliminary Financial Statements in Compliance with SEC Rule 15c2-11...

NovelStem Announces NewStem, Ltd. was Selected by Illumina for its Global Illumina Accelerator

NovelStem Increases NewStem Ownership to 33% as NewStem Prepares for First-Half 2021 FDA Filing...

NovelStem Announces New Research Collaborations for Stem-Cell Technology Platform...

NovelStem Provides Shareholder Update

NovelStem Provides Shareholder Update

Hollywood Media Changes Name and Stock Symbol to Novel Stem International Corp. and “NSTM”...

Hollywood Media Completes Transformational Investment in NewStem, Israel-Based Developer...